<DOC>
	<DOCNO>NCT01771874</DOCNO>
	<brief_summary>The purpose study determinate effect pre-treatment bupropion , dopamine norepinephrine transporter inhibitor , pharmacodynamics pharmacokinetics 3,4-methylenedioxymethamphetamine ( MDMA , `` Ecstasy '' ) . The study provide understand dopaminergic regulation mood .</brief_summary>
	<brief_title>Influence Bupropion Effects MDMA</brief_title>
	<detailed_description>3,4-methylenedioxymethamphetamine ( MDMA , `` ecstasy '' ) widely use young people euphoric effect . MDMA release serotonin ( 5-HT ) , dopamine ( DA ) , norepinephrine ( NE ) . 5-HT release mainly contribute subjective effect MDMA whereas NE release involve cardiovascular psychostimulant effect MDMA . DA mediate reinforce addiction-related effect drug abuse unclear whether DA contribute acute effect MDMA human . To determine role DA transporter-mediated DA release acute response MDMA humans investigator test effect DA transporter inhibitor bupropion physiological subjective effect MDMA . The investigator use randomize double-blind placebo-controlled cross-over design four experimental session . Bupropion placebo administer MDMA placebo 16 healthy volunteer . Subjective cardiovascular response repeatedly assess throughout experiment plasma sample collect pharmacokinetics . The primary hypothesis bupropion reduce MDMA-induced increase positive mood .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>N-Methyl-3,4-methylenedioxyamphetamine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Age 18 45 Understanding German language Subjects understand procedure risk associate study Participants must willing adhere protocol sign consent form Participants must willing adhere protocol sign consent form Participants must willing drink alcoholfree liquid xanthinecontaining product ( coffee , black green tea , red bull , chocolate ) midnight even study session , well study day Participants must willing drive traffic vehicle within 48 h follow MDMA administration Women childbearing potential must negative pregnancy test beginning study must agree use effective form birth control . Pregnancy test repeat study session Body mass index : 1827 kg/m2 Chronic acute medical condition include clinically relevant abnormality physical exam , laboratory value , ECG . In particular : Hypertension ( &gt; 140/90 mmHg ) Hypotension ( SBP &lt; 85 mmHg ) . Personal firstgrade history seizure . Cardiac neurological disorder Current previous psychotic major affective disorder Psychotic major affective disorder firstdegree relatives Prior illicit drug use ( except tetrahydrocannabinol ( THC ) contain product ) 5 time time within previous 2 month Pregnant nursing woman Participation another clinical trial ( currently within last 30 day ) Use medication contraindicate otherwise interfere effect study medication ( monoamine oxidase inhibitor , antidepressant , sedative etc . ) Tobacco smoking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>MDMA</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>emotion</keyword>
	<keyword>Mechanism action MDMA</keyword>
	<keyword>Interaction study</keyword>
	<keyword>Effect MDMA bupropion emotion</keyword>
</DOC>